Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A22486 | 24520789 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [Study on the mechanism of action of total saponins of Panax notoginseng in ameliorating oxidative stress and insulin resistance in rats fed with high fat diet]. | 2014 | Details |
| A22488 | 24520400 | PLoS One | Association between noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver disease. | 2014 | Details |
| A22492 | 24519131 | Braz J Med Biol Res | Association of adult weight gain and nonalcoholic fatty liver in a cross-sectional study in Wan Song Community, China. | 2014 | Details |
| A22494 | 24517420 | Climacteric | Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women. | 2014 | Details |
| A22495 | 24517411 | Metab Syndr Relat Disord | Comparative effects of the renin-angiotensin system blockers on nonalcoholic fatty liver disease and insulin resistance in C57BL/6 mice. | 2014 | Details |
| A22501 | 24516489 | J Res Med Sci | The effect of magnesium supplementation and weight loss on liver enzymes in patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A22504 | 24512497 | J Clin Endocrinol Metab | Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance. | 2014 | Details |
| A22512 | 24500395 | Eur J Pediatr | Serum hepcidin levels and iron metabolism in obese children with and without fatty liver: case-control study. | 2014 | Details |
| A22522 | 24492753 | Am J Gastroenterol | Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging. | 2014 | Details |
| A22525 | 24491369 | Semin Pediatr Surg | Nonalcoholic fatty liver disease and bariatric surgery in adolescents. | 2013 | Details |
| A22528 | 24489924 | PLoS One | Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22529 | 24489777 | PLoS One | Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats. | 2014 | Details |
| A22532 | 24488901 | Eur Rev Med Pharmacol Sci | Non-alcoholic fatty liver disease (NAFLD) and MTHFR 1298A > C gene polymorphism. | 2014 | Details |
| A22534 | 24486145 | Diabetes Metab | Adiponectin: A multitasking player in the field of liver diseases. | 2014 | Details |
| A22541 | 24477042 | Am J Clin Nutr | Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals. | 2014 | Details |
| A22550 | 24471572 | J Clin Endocrinol Metab | Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents. | 2014 | Details |
| A22552 | 24468600 | J Pediatr Endocrinol Metab | Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease. | 2014 | Details |
| A22558 | 24463897 | Arq Bras Cir Dig | Nonalcoholic steatohepatitis on preoperative period of gastric bypass: lack of correlation with degree of obesity. | 2013 | Details |
| A22563 | 24461315 | Nutr Res | Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients. | 2013 | Details |
| A22565 | 24460502 | Gynecol Endocrinol | Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women. | 2014 | Details |
| A22580 | 24445219 | J Hepatol | Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension. | 2014 | Details |
| A22581 | 24445216 | J Hepatol | Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice. | 2014 | Details |
| A22588 | 24440943 | J Clin Gastroenterol | Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk. | 2015 | Details |
| A22589 | 24440936 | J Clin Gastroenterol | Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology. | 2015 | Details |
| A22593 | 24436353 | Am J Physiol Gastrointest Liver Physiol | Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice. | 2014 | Details |
| A22598 | 24428677 | Expert Opin Pharmacother | New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease. | 2014 | Details |
| A22605 | 24418844 | Int J Obes (Lond) | Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease. | 2013 | Details |
| A22607 | 24417951 | Best Pract Res Clin Endocrinol Metab | Adiponectin as a routine clinical biomarker. | 2013 | Details |
| A22618 | 24404139 | PLoS One | Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression. | 2014 | Details |
| A22626 | 24401223 | Atherosclerosis | Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. | 2013 | Details |
| A22628 | 24397589 | Lipids Health Dis | Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone. | 2014 | Details |
| A22630 | 24396693 | Endocrinol Metab (Seoul) | Association of serum adipocyte-specific Fatty Acid binding protein with Fatty liver index as a predictive indicator of nonalcoholic Fatty liver disease. | 2013 | Details |
| A22631 | 24396649 | Endocrinol Metab (Seoul) | Tumor Necrosis Factor-α as a Predictor for the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Follow-Up Study. | 2013 | Details |
| A22634 | 24393106 | Antioxid Redox Signal | Mitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin. | 2014 | Details |
| A22640 | 24390241 | Mol Biol Rep | Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease. | 2014 | Details |
| A22645 | 24385405 | Adv Ther | Effect of metformin on ballooning degeneration in nonalcoholic steatohepatitis (NASH): when to use metformin in nonalcoholic fatty liver disease (NAFLD). | 2014 | Details |
| A22647 | 24384368 | Semin Cell Dev Biol | Nuclear envelope-related lipodystrophies. | 2013 | Details |
| A22651 | 24381750 | J Nutr Metab | Cut-Off Values of Visceral Adiposity to Predict NAFLD in Brazilian Obese Adolescents. | 2013 | Details |
| A22652 | 24381427 | Indian J Clin Biochem | A Study of Carotid Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease. | 2012 | Details |
| A22653 | 24380887 | Biochem Pharmacol | Brain metabolic dysfunction at the core of Alzheimer's disease. | 2013 | Details |
| A22654 | 24379092 | Orv Hetil | [The role of fetuin-A in cardiovascular diseases]. | 2014 | Details |
| A22658 | 24378273 | Ann Hepatol | Effects of bile acid sequestration on hepatic steatosis in obese mice. | 2014 | Details |
| A22659 | 24378270 | Ann Hepatol | Statin use is not associated with liver related mortality. | 2014 | Details |
| A22661 | 24377455 | Nutrition | Effects of bayberry juice on inflammatory and apoptotic markers in young adults with features of non-alcoholic fatty liver disease. | 2014 | Details |
| A22662 | 24377452 | Nutrition | Central obesity and altered peripheral adipose tissue gene expression characterize the NAFLD patient with insulin resistance: Role of nutrition and insulin challenge. | 2014 | Details |
| A22671 | 24373555 | Nutr J | Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial. | 2013 | Details |
| A22672 | 24373179 | Diabetes Obes Metab | APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome. | 2014 | Details |
| A22678 | 26528002 | Clujul Med | From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome? | 2014 | Details |
| A22683 | 26058106 | Eksp Klin Gastroenterol | [New metabolic index in the diagnosis of insulin resistance in patients with nonalcoholic fatty liver disease]. | 2014 | Details |
| A22684 | 26015978 | Mol Ther Methods Clin Dev | AAV8-mediated Sirt1 gene transfer to the liver prevents high carbohydrate diet-induced nonalcoholic fatty liver disease. | 2014 | Details |
| A22687 | 25937854 | EPMA J | 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics. | 2014 | Details |
| A22692 | 25859286 | Clin Epigenetics | Leucine alters hepatic glucose/lipid homeostasis via the myostatin-AMP-activated protein kinase pathway - potential implications for nonalcoholic fatty liver disease. | 2014 | Details |
| A22707 | 24366230 | Curr Opin Lipidol | Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field. | 2014 | Details |
| A22710 | 24365277 | Med Hypotheses | Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients. | 2013 | Details |
| A22713 | 24363514 | World J Gastroenterol | Cross-talk between the thyroid and liver: a new target for nonalcoholic fatty liver disease treatment. | 2013 | Details |
| A22714 | 24362075 | J Hepatol | Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation. | 2013 | Details |
| A22715 | 24361606 | Biochim Biophys Acta | Lipoic acid prevents fructose-induced changes in liver carbohydrate metabolism: role of oxidative stress. | 2013 | Details |
| A22718 | 24360972 | J Diabetes Complications | Serum ferritin is associated with non-alcoholic fatty liver disease and decreased Β-cell function in non-diabetic men and women. | 2013 | Details |
| A22721 | 24358044 | Hepat Mon | The effect of helicobacter pylori eradication on liver fat content in subjects with non-alcoholic Fatty liver disease: a randomized open-label clinical trial. | 2013 | Details |
| A22731 | 24351080 | Liver Int | Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22736 | 24348536 | Gastroenterol Res Pract | Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls. | 2013 | Details |
| A22741 | 24342243 | Food Chem Toxicol | The ethanol extract of Zingiber zerumbet Smith attenuates non-alcoholic fatty liver disease in hamsters fed on high-fat diet. | 2013 | Details |
| A22746 | 24335764 | Int J Obes (Lond) | Kefir improves fatty liver syndrome by inhibiting the lipogenesis pathway in leptin-deficient ob/ob knockout mice. | 2013 | Details |
| A22747 | 24333862 | J Hepatol | A population-based study on the prevalence of NASH using scores validated against liver histology. | 2013 | Details |
| A22748 | 24333444 | Biochem Biophys Res Commun | Mechanisms underlying hypertriglyceridemia in rats with monosodium L-glutamate-induced obesity: evidence of XBP-1/PDI/MTP axis activation. | 2013 | Details |
| A22755 | 24327959 | Mol Metab | Phenotypic comparison of common mouse strains developing high-fat diet-induced hepatosteatosis. | 2013 | Details |
| A22757 | 24327268 | Hepatology | Hepatocyte-specific Ptpn6 deletion promotes hepatic lipid accretion, but reduces NAFLD in diet-induced obesity: potential role of PPARγ. | 2014 | Details |
| A22762 | 24324835 | PLoS One | Nutrigenomics of high fat diet induced obesity in mice suggests relationships between susceptibility to fatty liver disease and the proteasome. | 2013 | Details |
| A22765 | 24322742 | Hepatobiliary Pancreat Dis Int | Novel anti-diabetic agents in non-alcoholic fatty liver disease: a mini-review. | 2013 | Details |
| A22766 | 24322188 | Arq Gastroenterol | Nonalcoholic fatty liver disease in menopausal women. | 2014 | Details |
| A22767 | 24321741 | Eur J Med Res | Dietary fructose enhances the incidence of precancerous hepatocytes induced by administration of diethylnitrosamine in rat. | 2013 | Details |
| A22768 | 24321532 | J Pediatr | Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease. | 2013 | Details |
| A22771 | 24320032 | Curr Pharm Des | The metabolic syndrome and chronic liver disease. | 2014 | Details |
| A22775 | 24316518 | J Hepatol | Dietary glycotoxins exacerbate progression of experimental fatty liver disease. | 2013 | Details |
| A22778 | 24314869 | J Nutr Biochem | Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet. | 2013 | Details |
| A22780 | 24313052 | Rev Med Suisse | [Dysmetabolic hyperferritinemia: a new target for treatment?]. | 2013 | Details |
| A22784 | 24306155 | Obes Res Clin Pract | Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease. | 2014 | Details |
| A22792 | 24302567 | Mol Nutr Food Res | Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds. | 2013 | Details |
| A22797 | 24298105 | Clin Med (Lond) | Low vitamin D levels are associated with increased risk for fatty liver disease among non-obese adults. | 2013 | Details |
| A22798 | 24297186 | Rev Endocr Metab Disord | Adiponectin signaling in the liver. | 2014 | Details |
| A22799 | 24295779 | Biochim Biophys Acta | Omega-3 phospholipids from fish suppress hepatic steatosis by integrated inhibition of biosynthetic pathways in dietary obese mice. | 2014 | Details |
| A22808 | 26355775 | J Clin Transl Hepatol | Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention. | 2013 | Details |
| A22810 | 26202295 | Hepatol Int | Lean NASH: distinctiveness and clinical implication. | 2013 | Details |
| A22811 | 26202294 | Hepatol Int | An integrated view of liver injury and disease progression in nonalcoholic steatohepatitis. | 2013 | Details |
| A22815 | 26182139 | Clin J Gastroenterol | A rapidly progressive and fatal case of nonalcoholic steatohepatitis following pancreaticoduodenectomy. | 2013 | Details |
| A22823 | 24284392 | Int J Mol Sci | Lessons from mouse models of high-fat diet-induced NAFLD. | 2013 | Details |
| A22825 | 24282628 | Oxid Med Cell Longev | Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease. | 2013 | Details |
| A22826 | 24280560 | Med Hypotheses | Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction. | 2013 | Details |
| A22828 | 24277674 | Curr Diab Rep | Nonalcoholic fatty liver disease and type 2 diabetes in obese children. | 2014 | Details |
| A22831 | 24275711 | J Clin Gastroenterol | The prevalence of elevated alanine transaminase and its possible causes in the general Korean population. | 2014 | Details |
| A22832 | 24275555 | Biochim Biophys Acta | Peri-conceptional obesogenic exposure induces sex-specific programming of disease susceptibilities in adult mouse offspring. | 2013 | Details |
| A22837 | 24274877 | Clin Liver Dis | The interactions of nonalcoholic fatty liver disease and cardiovascular diseases. | 2013 | Details |
| A22841 | 24274872 | Clin Liver Dis | The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease. | 2014 | Details |
| A22842 | 24274870 | Clin Liver Dis | The impact of obesity and metabolic syndrome on chronic hepatitis C. | 2013 | Details |
| A22843 | 24274869 | Clin Liver Dis | Surgical management of obesity in patients with morbid obesity and nonalcoholic fatty liver disease. | 2013 | Details |
| A22845 | 24274867 | Clin Liver Dis | The role of diet and nutritional intervention for the management of patients with NAFLD. | 2013 | Details |
| A22846 | 24274866 | Clin Liver Dis | The role of medications for the management of patients with NAFLD. | 2013 | Details |
| A22847 | 24274865 | Clin Liver Dis | Obesity and NAFLD: the role of bacteria and microbiota. | 2013 | Details |
| A22848 | 24274863 | Clin Liver Dis | The impact of obesity on liver histology. | 2013 | Details |
| A22849 | 24274862 | Clin Liver Dis | Obesity-associated nonalcoholic fatty liver disease. | 2013 | Details |